Regulatory T lymphocytes in traumatic brain injury

Neurochem Int. 2024 Feb:173:105660. doi: 10.1016/j.neuint.2023.105660. Epub 2023 Dec 25.

Abstract

Traumatic brain injury (TBI) presents a significant global health challenge with no effective therapies developed to date. Regulatory T lymphocytes (Tregs) have recently emerged as a potential therapy due to their critical roles in maintaining immune homeostasis, reducing inflammation, and promoting brain repair. Following TBI, fluctuations in Treg populations and shifts in their functionality have been noted. However, the precise impact of Tregs on the pathophysiology of TBI remains unclear. In this review, we discuss recent advances in understanding the intricate roles of Tregs in TBI and other brain diseases. Increased knowledge about Tregs may facilitate their future application as an immunotherapy target for TBI treatment.

Keywords: Cell therapy; Neuroinflammation; Neuroprotection; Regulatory T cell; Traumatic brain injury.

Publication types

  • Review

MeSH terms

  • Brain
  • Brain Injuries, Traumatic* / therapy
  • Humans
  • Inflammation
  • T-Lymphocytes, Regulatory*